Influenza: Prediction is worth a shot

Nature

Volumn 507, Issue 7490, 2014, Pages 47-48

  Koelle, Katia ^a   Rasmussen, David A ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

COST-BENEFIT ANALYSIS; DISEASE PREVALENCE; EPIDEMIOLOGY; HEALTH RISK; INFLUENZA; PREDICTION; PUBLIC HEALTH;

GENETIC DISTANCE; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; PRIORITY JOURNAL; PROTEIN STABILITY; SEASONAL INFLUENZA; SHORT SURVEY; VIRUS GENOME; VIRUS MUTATION; VIRUS STRAIN;

EVOLUTION, MOLECULAR; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 84895886748     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13054     Document Type: Short Survey

References (6)

1. Łuksza, M. & Lässig, M. Nature 507, 57-61 (2014).
2. Stöhr, K. Lancet Infect. Dis. 2, 517 (2002).
3. Carrat, F. & Flahault, A. Vaccine 25, 6852-6862 (2007).
4. Russell, C. A. et al. Vaccine 26 (Suppl. 4), D31-D34 (2008).
5. Smith, D. J. et al. Science 305, 371-376 (2004).
6. Medlock, J. & Galvani, A. P. Science 325, 1705-1708 (2009).